mymediset
28.3.2024 12:12:56 CET | ACCESS Newswire | Press release
FREIBURG, GERMANY / ACCESSWIRE / March 28, 2024 / mymediset, the leading provider of SAP solutions for the medical device industry, and Terso Solutions, the leading provider of RFID tracking solutions for the life sciences and healthcare markets, have today announced a new partnership to launch mymediset LiveSync, a revolutionary platform that will transform the way consigned inventory is identified, managed and tracked across mission-critical supply chains worldwide.
The new platform combines mymediset's cloud-based SAP automation solutions and Terso's RAIN RFID enclosures (cabinets, freezers, refrigerators) and sensors to provide real-time visibility and control of consigned products in the life sciences industries, such as medical devices, loaner kits, and pharmaceuticals. The platform, which will be launched in Q3/2024, is the first of its kind to combine live tracking and inventory data for medical and pharmaceutical consignments that is integrated into an intelligent, open, and extensible platform that provides complete visibility and control across the full product lifecycle from manufacture-to-disposal or recycling.
"This co-innovation initiative was brought together by mymediset and Terso Solutions in response to the multi-billion-dollar problem of inventory over-stocking caused by lack of real-time visibility and missing tracking data 'dead zones' that occur as consignments cycle through the different supply chain systems operated by manufacturers, distributors, and hospitals," said Michael Knauer, CEO & Founder of mymediset.
Joe Pleshek, CEO and President of Terso Solutions added: "Current industry estimates project, that several billion dollar of excess, unrecorded, or lost inventory may exist to assure product availability in mission-critical healthcare and lifesciences environments. With consignment records spanning numerous siloed systems and fragmented data sources, activities such as integrated planning, inventory rationalization and efficient automation of operations such as replenishment, disposal and recycling have so far been too costly and too complex for any one operator to resolve."
Knauer continued: "With our new mymediset LiveSync solution, we can now connect MedTech and Pharma manufacturers, distributors, and hospitals in a seamless, visible lifecycle, enabling customers to see, know, optimize, and automate every consignment wherever it is in the cycle. This provides an invaluable solution that can be used to rationalize inventory levels, reduce costs, improve patient safety, and comply with regulatory requirements and it provides the fundamental building block for our customers to create next-generation supply chains."
mymediset LiveSync Benefits:
- Brings together the market leading capabilities of mymediset and Terso Solutions. Combining mymediset's platform, a software-as-a-service (SaaS) solution and Terso's RAIN RFID enabled enclosures and sensors, to automatically capture consignment movements in real time. Automates the entire consignment process, from order placement to invoicing, using smart algorithms and data analytics to manage complex consignment and field inventory processes inside SAP.
- Connects all stakeholders involved in the consignment cycle and provides them with actionable insights and reports on inventory status, consumption, expiration, and replenishment.
- Terso's RFID enclosures and sensors are connected to the cloud and transmit the inventory data to mymediset's platform in real-time, eliminating the need for manual scanning, counting, or reporting. The enclosures provide secure access control and track environmental data including temperature to ensure product integrity.
- A seamless and scalable cloud-based SaaS solution for consignment automation that will benefit both suppliers and customers. The product will enable suppliers to increase sales, improve cash flow, and enhance customer satisfaction by ensuring the right products are available at the right time and place.
- Enable customers to reduce inventory waste, avoid stock-outs, and improve patient outcomes by having access to the latest supplies, equipment, and devices, instantly locatable at the touch of a button.
Commenting on the partnership both CEOs pointed to the potential for customers to gain significant value from the new combination:
"We are very excited to partner with Terso Solutions and leverage their expertise and innovation in RFID technology. Together, we will offer a unique and powerful platform that will solve the challenges and inefficiencies of consignment management in the medical and life sciences industries. Our product will create value for our customers and help them achieve new levels of operational excellence and competitive advantage as they take on the challenge of running leaner, faster inventory lifecycles in next-generation supply chains driven by real-time data and assisted by AI. Two market leaders have come together to bring real-time transparency to the healthcare and life sciences industries. Finally, now we know what, where, and when products have been consumed, in real time" said Knauer.
"We are thrilled to partner with mymediset and integrate their SAP-based Enterprise SaaS platform with our RFID enabled solutions. Both mymediset and Terso have a proven track record of delivering consignment automation solutions that are trusted in the most demanding, mission-critical environments. Our product will provide a complete and end-to-end solution for consignment automation that will revolutionize the way consigned inventory is managed and tracked. With this innovative solution, We Know Now." said Pleshek.
The new product will be available for pre-order in April 2024 and will be launched in Q3 2024.
About mymediset
mymediset is the leading provider of cloud-based automation solutions for the medical device industry that specializes in managing complex loan, consignment, and field inventory processes inside SAP®. mymediset offers a platform that connects medical device and pharma manufacturers, distributors, hospitals, and clinics, and enables them to manage and track their consigned inventory in real-time. mymediset helps its customers reduce costs, increase sales, and optimize inventory levels, while ensuring compliance and patient safety.
About Terso Solutions, Inc.
Terso Solutions, Inc. is the leading provider of automated inventory management solutions for tracking high-value medical and scientific products in healthcare and life science. Terso is backed by 18 years of RFID product development and implementation experience, with a product line that includes RAIN RFID cabinets, refrigerators, freezers (-86°C to -5°C), read points, mobile solutions, and rooms. Terso has deployed over 3,500 RAIN RFID-enabled devices worldwide and provides inventory automation at over 1,000 U.S. healthcare facilities. Headquartered in Madison, WI, with additional offices in Walldorf, Germany and Tokyo, Japan, Terso Solutions, Inc. is a wholly owned subsidiary of the Promega Corporation.
For press inquiries, please contact:
| mymediset: | |
| Gloriela Rosas | |
| LiveSync@mymediset.cloud | |
| Phone: | |
| North America: +1 (617) 506 9850 | |
| Europe: +49 (761) 556-5580 | |
| Terso Solutions: | |
| Katie Anderson | |
| katie.anderson@tersosolutions.com | |
| Phone: | +1 (608) 960-7376 |
| For more information, please visit: | |
| mymediset: | https://mymediset.net/ |
| https://mymediset.net/livesync/ | |
| Terso Solutions: | www.tersosolutions.com |
SOURCE: mymediset
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
As the UK Backs Life Sciences and Advanced Manufacturing, US PMO Firm MustardSeed Moves In to Help Deliver It16.7.2026 11:00:00 CEST | Press release
The expansion reflects growing client demand for embedded programme management support across highly regulated industries. WEST CHESTER, PA AND MANCHESTER, UK / ACCESS Newswire / July 16, 2026 / The UK Government's 2025 Modern Industrial Strategy has put life sciences, advanced manufacturing, defence, and clean energy at the centre of Britain's growth agenda. MustardSeed, a US-based programme management and PMO consultancy, is launching UK operations to help organisations in those sectors deliver on that ambition. The 2025 Modern Industrial Strategy names life sciences and advanced manufacturing among its eight priority sectors, alongside defence and clean energy. These are industries defined by complex, regulated, multi-stakeholder programmes where disciplined execution directly determines commercial and operational outcomes. MustardSeed, headquartered in West Chester, Pennsylvania, has built its practice around delivering that execution. The firm announced today the launch of its UK
Akkodis Recognized in the 2026 Gartner(R) Emerging Market Quadrant for Physical AI Services16.7.2026 06:45:00 CEST | Press release
Akkodis continues to advance full-stack engineering expertise and industrial-grade AI deployments. ZURICH, SWITZERLAND / ACCESS Newswire / July 16, 2026 / Akkodis, a global digital engineering consulting company and part of the Adecco Group, has been recognized as a Specialist in the Gartner Emerging Market Quadrant for Physical AI Services (PAIS), published on June 8, 2026. Physical AI services address the complex challenge of designing, developing, deploying and operating AI‑enabled physical systems - such as robots, autonomous systems including, vehicles, drones and industrial infrastructure - in real‑world environments. The Gartner report states "The PAIS market is moving from exploratory experimentation toward operational reliability at scale. This trend is driven by mounting labor constraints, safety requirements, infrastructure modernization and advances in AI, simulation and automation technologies." Full‑stack Physical AI capabilities with real‑world impact and measurable outc
Loar Holdings Inc. Announces Date and Time for Second Quarter 2026 Earnings and Conference Call15.7.2026 22:15:00 CEST | Press release
WHITE PLAINS, NY / ACCESS Newswire / July 15, 2026 / Loar Holdings Inc. (NYSE:LOAR) will report Q2 2026 earnings before the market opens on Thursday, August 6, 2026. A conference call will follow at 11:00a.m. Eastern Time. To participate in the call telephonically please dial +1 877-407-0670 / +1 215-268-9902. International participants can find a list of toll-free numbers here. A live audio webcast will also be available at the following link as well as through the Investor section of Loar Holdings website: https://ir.loargroup.com The webcast will be archived and available for replay later in the day. About Loar Holdings Inc. Loar Holdings Inc. is a diversified manufacturer and supplier of niche aerospace and defense components that are essential for today's aircraft and defense systems. Loar has established relationships across leading aerospace and defense original equipment manufacturers and Tier Ones worldwide. Contact Ian McKillop Loar Holdings Inc. Investor Relations IR@loargro
Fermi Outlines Strategic Rationale for Upsized $431 Million Convertible Notes Offering15.7.2026 14:30:00 CEST | Press release
Flexible convertible structure with shareholder-friendly capped call minimizes dilution Proceeds strengthen liquidity in midst of customer and partner negotiations and preserve Fermi's speed-to-power advantage Attractive five-year cost of capital provides run room to advance multiple commercial tracks in parallel DALLAS, TX / ACCESS Newswire / July 15, 2026 / Fermi Inc. (Nasdaq:FRMI)(LSE:FRMI), operating as Fermi America™ ("Fermi" or the "Company"), outlined today the strategic rationale for its recently closed and upsized offering of $431.25 million aggregate principal amount of 5.00% Convertible Senior Notes due 2031 (the "Notes"), which included the exercise in full of the initial purchasers' 13-day option to purchase up to an additional $56.25 million aggregate principal amount of Notes. The Notes are intended to strengthen Fermi's balance sheet, enhance liquidity, and support continued execution of Project Matador as the Company advances tenant, strategic partnership, and power-de
Innodata to Report Second Quarter 2026 Results15.7.2026 14:30:00 CEST | Press release
NEW YORK CITY, NY / ACCESS Newswire / July 15, 2026 / INNODATA INC. (NASDAQ:INOD) today announced that it will report Second Quarter 2026 results after the market closes on Thursday, August 6, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 715 9871 North America, Toll Free (+44) 800 358 0970 United Kingdom (+1) 646 307 1963 International Participant Access Code 3150581 For Replay: (+1) 800 770 2030 North America-Toll Free (+44) 203 433 3849 (+1) 609 800 9909 United Kingdom International Playback ID 3150581# Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
